IP Library Granted Patent US 10,143,804
Granted Patent B2
US 10,143,804 · App. 15/164,148 · Granted Dec 4, 2018

Biopolymer-based emulsion lubricants for syringe barrels

Inventors: Frederick Talley Gertz (Riverside, CA); Jaan Noolandi (La Jolla, CA); Robert James Schultheis (Temecula, CA)
Assignee: ZebraSci, Inc
A61M5/3129C10M145/40C10M173/02A61M2005/3131C10M2209/12C10M2229/025C10N2230/02C10N2230/06C10N2240/66C10N2250/02C10N2250/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,143,804
App. No.
15/164,148
Granted
Dec 4, 2018
Kind
B2
Abstract

A stable biopolymer-based emulsion lubricant including Agar is provided to reduce the friction between a syringe barrel plunger and the interior surface of the syringe barrel. According to exemplary embodiments the emulsion has a friction of less than 4N, the emulsion is temperature stable in a range of 4-23 degrees Celsius and the emulsion is stable for a period of at least 60 days.

Claims (16)

1. A medical drug delivery device, comprising: a syringe barrel with an interior surface lubricated with an emulsion of a hydrophobic liquid oil in a matrix of water-soluble polysaccharides, wherein one type of the polysaccharides is Agar.

2. The device as set forth in claim 1 , wherein the emulsion comprises 1-10 percent Agar.

3. The device as set forth in claim 1 , wherein the polysaccharides further comprise Xantham Gum, Dextrum, Cellulose, or a combination thereof.

4. The device as set forth in claim 1 , wherein the emulsion has a friction of less than 4N.

5. The device as set forth in claim 1 , wherein the emulsion is temperature stable in a range of 4-23 degrees Celsius.

6. The device as set forth in claim 1 , wherein the emulsion is stable for a period of at least 60 days.

7. The device as set forth in claim 1 , wherein the hydrophobic liquid oil has a viscocity in the range 20-12,500 cSt.

8. A method of lubricating a medical drug delivery device, comprising spraying an emulsion onto the interior surface of a syringe barrel, wherein the emulsion comprises of a hydrophobic liquid oil on a matrix of water-soluble polysaccharides, wherein one type of the polysaccharides is Agar.

9. The method as set forth in claim 8 , wherein the emulsion is sprayed on with a volume of 0.5-10 microliter and with a flow rate of 1-5 standard liter per minute.

10. The method as set forth in claim 8 , wherein the spaying starts at about 30 mm outside the syringe barrel and stops at about 40 mm inside the syringe barrel for a duration of about 1 second.

11. The method as set forth in claim 8 , wherein the emulsion comprises 1-10 percent agar.

12. The method as set forth in claim 8 , wherein the polysaccharides further comprise Xantham Gum, Dextrum, Cellulose, or a combination thereof.

13. The method as set forth in claim 8 , wherein the emulsion has a friction of less than 4N.

14. The method as set forth in claim 8 , wherein the emulsion is temperature stable in a range of 4-23 degrees Celsius.

15. The method as set forth in claim 8 , wherein the emulsion is stable for a period of at least 60 days.

16. The method as set forth in claim 8 , wherein the hydrophobic liquid oil has a viscocity in the range 20-12,500 cSt.

Assignments (2)
SECURITY INTEREST Recorded Jun 27, 2018
From: ZEBRASCI, INC.
To: SCANDINAVIAN HEALTH LTD.
Reel/Frame 046218/0543 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2016
From: GERTZ, FREDERICK TALLEY; NOOLANDI, JAAN; SCHULTHEIS, ROBERT JAMES
To: ZEBRASCI, INC
Reel/Frame 038727/0443 →
Continuity (2)
Provisional Application 62168102 · May 29, 2015
Related Publication 20160346477A1 · Dec 1, 2016